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Abstract
Background: Most methods available to predict protein epitopes are sequence based. There is a
need for methods using 3D information for prediction of discontinuous epitopes and derived
immunogenic peptides.
Results: PEPOP uses the 3D coordinates of a protein both to predict clusters of surface accessible
segments that might correspond to epitopes and to design peptides to be used to raise antibodies
that target the cognate antigen at specific sites. To verify the ability of PEPOP to identify epitopes,
13 crystallographically defined epitopes were compared with PEPOP clusters: specificity ranged
from 0.75 to 1.00, sensitivity from 0.33 to 1.00, and the positive predictive value from 0.19 to 0.89.
Comparison of these results with those obtained with two other prediction algorithms showed
comparable specificity and slightly better sensitivity and PPV. To prove the capacity of PEPOP to
predict immunogenic peptides that induce protein cross-reactive antibodies, several peptides were
designed from the 3D structure of model antigens (IA-2, TPO, and IL8) and chemically synthesized.
The reactivity of the resulting anti-peptides antibodies with the cognate antigens was measured. In
80% of the cases (four out of five peptides), the flanking protein sequence process (sequence-
based) of PEPOP successfully proposed peptides that elicited antibodies cross-reacting with the
parent proteins. Polyclonal antibodies raised against peptides designed from amino acids which are
spatially close in the protein, but separated in the sequence, could also be obtained, although they
were much less reactive. The capacity of PEPOP to design immunogenic peptides that induce
antibodies suitable for a sandwich capture assay was also demonstrated.
Conclusion: PEPOP has the potential to guide experimentalists that want to localize an epitope
or design immunogenic peptides for raising antibodies which target proteins at specific sites. More
successful predictions of immunogenic peptides were obtained when a peptide was continuous as
compared with peptides corresponding to discontinuous epitopes. PEPOP is available for use at
http://diagtools.sysdiag.cnrs.fr/PEPOP/.
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Background
In antibody-antigen (Ab-Ag) interactions, the paratope of
the Ab binds to the epitope of the Ag. The identification of
epitopes is an important step for understanding molecu-
lar recognition rules and is also helpful for diagnosis of
diseases and for drug and vaccine design. The ultimate
method to precisely define an epitope is to solve the 3D
structure of the Ab-Ag complex either by X-ray crystallog-
raphy or NMR [1]. These techniques are, however,
demanding and generally time-consuming. Faster epitope
identification methods have been described such as site-
directed mutagenesis of the Ag [2,3]. Another popular
approach to map an epitope is parallel peptide synthesis
[4,5], based on the synthesis of overlapping peptides cov-
ering the entire Ag sequence. In this case, mainly continu-
ous (sequential or linear) epitopes can be identified.
Screening chemical or biological combinatorial libraries
[6] for Ab binders allows selection of peptides also called
mimotopes [7], mimicking more or less faithfully the
epitope. Bioinformatics tools have been developed to
help experimentalists in localizing the epitope by the
sequence analysis of the selected mimotopes [8,9].
Synthetic peptides are commonly used as immunogens to
raise anti-peptide Abs that may cross-react with proteins
[10], thus allowing their detection and quantification.
These peptides are generally designed by using methods
that attempt to predict antigenic determinants of a pro-
tein. Numerous algorithms have been developed over the
past 25 years. They are based on different theoretical phys-
icochemical characteristics of the target protein such as
hydrophilicity, flexibility, accessibility, and secondary
structure, especially turns [11]. Other methods are combi-
nations of the latter approaches [12], the most recent [13]
being an extension and combination of the methods of
Parker et al. [14] and Jameson and Wolf [15]. Likewise,
Welling et al. [16] developed an antigenicity scale, with
the aim of predicting antigenic regions and synthesizing
the corresponding antigenic peptides to elicit Abs reactive
with the intact protein. All these algorithms have led to
the development of several softwares or web interfaces
that make the use of such methods very easy. It is, how-
ever, difficult to assess the efficacy of all predictive meth-
ods. A comparative study published some years ago
[11,17] indicated that the most accurate predictive
method at that time is based on the prediction of turns.
This method was implemented in BEPITOPE [18]. A more
recent and more exhaustive comparative study [19] con-
cluded that the methods based on sequence analysis do
not predict epitopes better than chance.
All these methods predict antigenic determinants from
the protein sequence alone, neglecting 3D structure infor-
mation. This is surprising because the 3D structure of an
increasing number of proteins has been solved by X-ray
crystallography or NMR, and predictive modeling meth-
ods are available that show increasing accuracy [20].
Recently, however, a few recent studies [21-24] propose
bioinformatics tools based on 3D information to predict
epitopes.
In this article, we describe PEPOP, an algorithm that
makes use of the 3D information of a protein to predict
peptides which could serve as immunogens to raise site-
specific anti-protein Abs. Clusters of surface accessible
segments of the protein are first identified by PEPOP, and
this information is further used to design the peptides. We
analyzed how PEPOP clusters corresponded to structur-
ally defined epitopes (dataset of 13 epitopes on 8 anti-
gens) and how Abs raised against peptides designed by
PEPOP reacted with the parent protein.
Results
Clustering of exposed segments of the Ag
A- PEPOP features and outputs for clustering
We developed the PEPOP algorithm as a new method
intended to identify peptide sequences that, when
injected into animals, induce the production of Abs that
should recognize specific areas of a protein. From the 3D
structure of a protein, PEPOP first identifies segments
composed of accessible and sequence contiguous amino
acids. Then, these segments are clustered according to
their spatial distances (Figure 1A). Clusters and their seg-
ments are then further used to design immunogenic pep-
tides. The PEPOP interface was designed so as to provide
both detailed information (atomic coordinates, distance
matrix, etc.) and modifiable views of the cluster(s) in the
3D context of the protein (Figure 1B).
B- Experimental evaluation of PEPOP capacity to predict antigenic 
epitopes
Since there is a documented relationship between surface
accessibility and antigenicity [25,26], we first evaluated
the correspondence between the surface clusters identified
by the PEPOP algorithm on given proteins and their
known epitopes. To this end, 13 Ab-Ag complexes for
which the amino acids composing the discontinuous
epitope have been identified precisely were studied
(selected from the literature and from the PDB [27]). A
detailed analysis was first carried out on hen egg lysozyme
(HEL) because several structurally, well-defined epitopes
have been identified (Table 1) by X-ray crystallography
(resolutions from 1.5 to 3.22 Å). The PEPOP algorithm
was run on the 3D structure of HEL [PDB: 1SFG]. PEPOP
identified 23 segments of accessible residues which were
automatically grouped into four clusters on the surface of
HEL (Table 1). Cluster 1 contains antigenic residues
belonging to three epitopes (D11.15, HyHEL-10, and
HyHEL-63). Cluster 2 exactly matches the D1.3 epitope
and 9 of 10 residues of the D11.15 epitope; it also predictsBMC Bioinformatics 2008, 9:71 http://www.biomedcentral.com/1471-2105/9/71
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PEPOP Figure 1
PEPOP. (A) Description of PEPOP. Step 1: The solvent accessible surface area is calculated from the 3D structure of a pro-
tein. Step 2: Segments of accessible and contiguous amino acids are listed, and the shortest Euclidian distance matrix between 
segments is calculated. Step 3: The segments are clustered according to the matrix (clusters can be displayed on the 3D struc-
ture of the Ag). Step 4: Peptides are designed according to the clustering analyses. (B) The PEPOP interface. Segments and 
clusters can interactively be displayed on a 3D view of the Ag.
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some of the antigenic residues of the HyHEL-10 and
HyHEL-63 epitopes. Cluster 3 perfectly matches the
D44.1 epitope and almost perfectly the HyHEL-5 epitope
(13 of 14 residues); it also predicts part of the HyHEL-10
and HyHEL-63 epitopes. Cluster 4 does not correspond to
any X-ray described epitope of the lysozyme.
Next, seven additional Ab-Ag complexes were analyzed to
extend these observations to a database of 13 crystallo-
graphic epitopes (Table 2). PEPOP analyses were per-
formed on the 3D structures of the Ag alone, i.e., not
complexed with the mAb specific for the epitope studied
because this is the most frequently encountered case. The
distribution of the amino acids in the epitope among the
clusters identified by PEPOP was analyzed, and the
number of the amino acids in the epitope in the major
cluster (cluster containing the greatest number of amino
acids of the epitope) was calculated. The results show that
the experimentally identified amino acids in the epitope
belong to a single cluster for the D1.3, D44.1, and HyHEL-
5 epitopes in HEL and the 5G9 epitope in tissue factor, to
two clusters for the D11.15 epitope in HEL and the Jel42
epitope in the histidine-containing phosphocarrier pro-
tein HPr or to three clusters for the complexes BH151 –
hemagglutinin, Bo2C11 – C2 domain of FVIII, NC41 –
neuraminidase, F9.13.7 – guinea fowl lysozyme (GEL),
HyHEL-10 – HEL, HyHEL-63 – HEL, and N10 – staphylo-
coccal nuclease (SN). For example, all the amino acids of
the epitope on HEL recognized by mAb D44.1 are
included in a single cluster identified by PEPOP (Figure
2A), and 13 amino acids out of 16 of the epitope on HPr
recognized by mAb Jel42 are included in the major cluster
(Figure 2B). Table 2 shows that the specificity of the
method ranged from 0.75 to 1.00 (median value 0.87)
and the sensitivity varied within a broader range (0.33 to
1.00; median value: 0.63). The positive predictive value
(PPV) varied from 0.19 to 0.89 (mean value 0.43; median
value 0.33). The same database of 13 crystallographically
Table 1: Distribution of the residues of the HEL epitopes in the clusters identified by PEPOP
PEPOP 
cluster
PEPOP 
segment
Position 
([PDB: 1SFG] 
chain A)
mAb1
D1.3 D11.15 D44.1 HyHEL-5 HyHEL-10 HyHEL-63
Cluster1 Segment17 93–94 1/10 (103) 7/16 (93, 96, 
97, 100, 101, 
102, 103)
7/23 (93, 96, 
97, 100, 101, 
102, 103)
Segment18 96–97
Segment19 100–103
Cluster2 Segment2 10–16 10/10 (13, 14, 19, 
21, 22, 24, 117, 
119, 121, 125)
9/10 (21, 23, 106, 
112, 113, 116, 
117, 118, 119)
5/16 (15, 16, 
19, 20, 21)
8/23 (13, 14, 
15, 16, 18, 19, 
20, 21)
Segment20 106–109
Segment21 111–114
Segment22 116–119
Segment23 121–129
Segment3 18–24
Segment4 27–28
Cluster3 Segment10 56–57 11/11 (41, 45, 
46, 47, 49, 53, 67, 
68, 70, 81, 84)
13/14 (41, 43, 
44, 45, 46, 47, 
(63, 73, 75, 48, 
49, 89) 53, 67, 
68, 70, 84)
4/16(63, 73, 
75, 89)
6/23 (62, 63, 
73, 75, 77, 89)
Segment11 59
Segment12 61–63
Segment13 65–68
Segment14 70–79
Segment15 81–82
Segment16 84–90
Segment8 41–49
Segment9 53
Cluster4 Segment1 1–8
Segment5 33–35
Segment6 37
Segment7 39
amino acids not accessible 1/14 (69) 2/23 (98, 99)
1 Ratio of the number of amino acids in the epitope included in the cluster to the total number of amino acids in the epitope. The epitopes were defined 
as in the original publication (D1.3 [54], D11.15 [55], D44.1 [56], HyHEL-5 [57], HyHEL-10 [58], HyHEL-63 [59]). Positions of the amino acids in the 
epitope included in the cluster are indicated in parentheses. The ratios are in bold for the major clusters.BMC Bioinformatics 2008, 9:71 http://www.biomedcentral.com/1471-2105/9/71
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defined epitopes was used with two freely available web
tools that also make use of the 3D information of the pro-
tein to predict epitopes (DiscoTope [23,28] and CEP
[24,29]). The results in Table 2 show that both methods
have similar specificity (median value for DiscoTope:
0.83; median value for CEP: 0.90). Their sensitivities,
however, are slightly lower than that of PEPOP (median
value for DiscoTope: 0.39; median value for CEP: 0.47)
and the PPV are again lower than that found for PEPOP
predictions (median value for DiscoTope: 0.17; median
value for CEP: 0.28) (Table 2). Thus, performances of
PEPOP compare well with similar, but not identical, algo-
rithms.
Design of peptides from clusters
A- PEPOP features and outputs for the design of immunogenic 
peptides
Based on PEPOP prediction of clusters of surface accessi-
ble segments, the design of peptides suitable for raising
Abs potentially cross-reactive with the target protein can
be achieved by different methods. To build in silico a can-
didate peptide, a segment, called a "reference segment", is
first chosen, and its sequence is extended with a "method
of extension" in a specified "area of extension" on the pro-
tein to yield the designed peptide. Each of the reference
segments, the method, and the area of extension can be
selected among several possibilities. Figure 3 illustrates
the method of adding the nearest neighbor (NN) seg-
ments to the reference segment to obtain a suitable pep-
tide. Peptides #5 and #6 in Table 3 were constructed from
the longest segment to which the nearest neighbor seg-
ments were added, according to two different methods
(respectively, NN and NNd, for segments synthesized
using D-amino acids). The software was developed in
such a way that, at each of the three steps of the design of
a given peptide, the user can choose the parameter (for
example, inclusion or not of a part of the protein in the
peptide) or let the algorithm automatically do it. By
default, the reference segment is the longest segment, the
method of extension is the addition of the protein
sequence and in this case it is not necessary to select an
area of extension. The peptide is therefore extended until
the default minimal length of 20 amino acids is reached.
Table 2: Evaluation and comparison of the performances of PEPOP
Ab – Ag complex1 PDB Epitope 
(number of 
amino acids)
PEPOP CEP DiscoTope
Number of clusters 
containing epitopic 
residues/total 
number of clusters
Number of 
predicted residues 
of the epitope
Sp Se PPV Sp Se PPV Sp Se PPV
D1.3 – hen egg lysozyme 
[54]
1SFG_A 1 0 1 / 4 1 0 0 . 7 71 . 0 00 . 2 70 . 7 61 . 0 00 . 2 60 . 8 00 . 4 00 . 1 4
D44.1 – hen egg 
lysozyme [56]
1T6V_M 1 1 1 / 5 1 1 0 . 8 11 . 0 00 . 3 30 . 7 80 . 9 10 . 2 80 . 8 60 . 5 50 . 2 7
HyHEL-5 – hen egg 
lysozyme [57]
1VDP_B 1 4 1 / 5 1 3 0 . 8 30 . 9 30 . 4 10 . 8 80 . 0 00 . 0 00 . 7 80 . 0 00 . 0 0
Jel42 – HPr [60] 1POH 1 6 2 / 8 1 3 0 . 9 30 . 8 10 . 7 20 . 9 00 . 7 50 . 6 30 . 9 70 . 0 60 . 3 3
D11.15 – hen egg 
lysozyme [55]
1HEL 10 2/5 8 0.95 0.80 0.57 0.90 0.10 0.08 0.82 0.30 0.13
5G9 – tissue factor [61] 1WV7_T 1 8 1 / 3 1 4 0 . 7 50 . 7 80 . 2 50 . 8 40 . 2 80 . 1 50 . 8 40 . 1 70 . 1 0
BH151 – hemagglutinin 
[62]
5HMG_C 1 9 3 / 7 1 2 0 . 8 30 . 6 30 . 1 90 . 9 70 . 3 20 . 4 00 . 7 50 . 1 10 . 0 3
Bo2C11 – FVIII C2 
domain [63]
1D7P_M 15 3/5 8 0.92 0.53 0.42 0.94 0.47 0.44 0.83 0.53 0.25
NC41 – neuraminidase 
[64]
1NMC_N 2 2 3 / 4 1 1 0 . 9 00 . 5 00 . 2 30 . 9 90 . 5 90 . 8 10 . 8 50 . 6 40 . 2 0
F9.13.7 – guinea fowl 
lysozyme [65]
1HHL 10 3/5 5 0.98 0.50 0.71 0.92 0.50 0.33 0.83 0.40 0.17
HyHEL-10 – hen egg 
lysozyme [58]
1UC0_A 16 3/5 8 0.99 0.50 0.89 0.96 0.56 0.64 0.87 0.44 0.32
HyHEL-63 – hen egg 
lysozyme [59]
1VFB_C 23 3/4 9 0.82 0.39 0.32 0.73 0.30 0.19 0.87 0.39 0.39
N10 – staphylococcal 
nuclease [66]
1EYO_A 18 3/6 6 0.87 0.33 0.29 0.88 0.06 0.07 0.66 0.33 0.13
Average 0.87 0.67 0.43 0.88 0.45 0.33 0.83 0.33 0.19
Median 0.87 0.63 0.33 0.90 0.47 0.28 0.83 0.39 0.17
1 The corresponding reference is given in parentheses
nd: not determined (no results returned from the server)
Sp: specificity; Se: sensibility; PPV: positive predictive value (see Materials and methods)BMC Bioinformatics 2008, 9:71 http://www.biomedcentral.com/1471-2105/9/71
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B- Experimental evaluation of the immunogenicity of designed 
peptides
To prove the capacity of PEPOP to successfully predict
peptides that are able to induce Abs able to recognize the
cognate protein, several peptides were designed from the
3D structure of three model Ags and chemically synthe-
sized, then rabbits were immunized with these peptides
(conjugated to a carrier protein), and the reactivity of the
resulting Abs with the cognate Ags was measured. From
the 3D structures of the PTP domain of IA-2, the MPO-like
domain of TPO, and IL8, PEPOP was run to predict clus-
ters of surface accessible residues and to design peptides
from them. Several of the possible methods to construct
peptides  in silico were used although not all could be
tested on the three Ags, thus precluding a strict compari-
son of methods. Nevertheless, five peptides (peptides
#4–8) were designed from the IA-2 model, four from the
TPO model (peptides #13–16), and two from the 3D
structure of IL8 (peptides #17 and #18). All but three of
the peptides predicted by PEPOP have the longest identi-
fied segment as reference segment. The other three pep-
tides started from the top-ranked segment either of the
top-ranked cluster (peptide #15) or of a user-selected clus-
ter (peptide #8 and #18). To predict the peptides, the sim-
plest method [the flanking protein sequence (FPS)
process] was first tested (peptides #4, #8, #13, #17, and
#18 in Table 3). Then, the ability of the software to predict
immunogenic peptides corresponding to a discontinuous
epitope of the protein was experimented with the use of
the NN method to design peptides #5, #6, #14 and #15.
The design process is illustrated in Figure 3. Some other
peptides were designed "manually", i.e., by using user-
defined information (peptides #7 and #16 in Table 3). To
evaluate the method, seven peptides (peptides #1, #2, #3,
#9, #10, #11, and #12) were predicted from the amino
acid sequence of TPO and IA-2 by using the standard algo-
rithm BEPITOPE [11]. This method predicts peptides
from the protein sequence, the corresponding epitopes
thus being continuous.
Synthetic peptides were prepared according to the
designed sequences, then coupled to KLH and used to
immunize rabbits. To satisfy the predictive goal, anti-pep-
tide polyclonal Abs must recognize the predicted peptide
and cross-react with the cognate protein. Table 3 presents
the reactivity with the cognate Ag of the Abs obtained by
immunization with the different peptides (all Abs reacted
strongly with the cognate peptide; results not shown). The
best results (highest ELISA reactivity with the Ag) were
obtained with peptides designed by the FPS method since
four out of five such peptides led to the production of Abs
that reacted strongly with the protein Ag (peptides #4 and
#8 with IA-2, peptide #13 with TPO, and peptide #18 with
IL8). Only peptide #17 failed to recognize the IL8 Ag. Pep-
tides designed by the FPS method of PEPOP led more fre-
quently to strongly reactive sera than peptides selected
according to the predictions of BEPITOPE: two control
peptides (#1 and #9) induced an Ab response of the same
quality (as measured by ELISA), whereas the five other
control peptides (peptide #2; #3, #10, and #12) gave rise
to medium-range reactivities (Table 3), and peptide #11
did not lead to any significant Ab response. The two pep-
tides (#7 and #16) that were "manually designed" as well
as the retro-inverso peptide (#6) did not lead to any sig-
nificant Ab response. Two peptides out of the four
designed by using the NN method of PEPOP gave inter-
mediate cross-reactivity with the cognate Ag reactivity
(peptides #14 and #15 on TPO). In summary, the simple
FPS method (which provides continuous sequences)
proved to be very efficient to yield peptides which, when
conveniently coupled to a suitable carrier, induced a
Comparison of known epitopes with the predicted major  cluster Figure 2
Comparison of known epitopes with the predicted 
major cluster. Amino acids in the epitope and in the major 
cluster are in green; those outside of the major cluster are in 
red; those non-accessible are in yellow; amino acids in the 
major cluster but not in the epitope are in blue. (A) Epitope 
on HEL recognized by mAb D44.1 (B) Epitope on HPr rec-
ognized by mAb Jel42.BMC Bioinformatics 2008, 9:71 http://www.biomedcentral.com/1471-2105/9/71
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Example of peptides designed from the 3D structure of IA-2 Figure 3
Example of peptides designed from the 3D structure of IA-2. The two peptides, #5 (A) and #6 (B) of Table 3, were 
constructed from the longest segment (segment 1: reference segment) to which were added the nearest neighbor segments 
(segment 2 to respectively segment 4 and segment 5), according to two different methods (respectively method NN and 
NNd). Segments indicated in the IA-2 sequence are in the same color as in the 3D structure.
310       320       330       340       350       360
RSCPIIVHCSDGAGRTGTYILIDMVLNRMAKGVKEIDIAATLEHVRDQRPGLVRSKDQFE
370         
FALTAVAEEVNAILKALPQ
310       320       330       340       350       360
RSCPIIVHCSDGAGRTGTYILIDMVLNRMAKGVKEIDIAATLEHVRDQRPGLVRSKDQFE
370         
FALTAVAEEVNAILKALPQBMC Bioinformatics 2008, 9:71 http://www.biomedcentral.com/1471-2105/9/71
Page 8 of 15
(page number not for citation purposes)
strong Ab response against the corresponding protein Ag.
Except in a few cases, more sophisticated design methods
(NN, NNd, and MD) that tried to reconstitute discontinu-
ous epitopes failed to propose peptides which had useful
immunogenic properties. As compared with peptides
designed from the standard method (BEPITOPE), PEPOP
performed equally well or even better.
C- Use of the PEPOP algorithm for sandwich immunoassay design
Since PEPOP is able to predict immunogenic peptides
localized on the surface of the 3D structure of a target pro-
tein, it could conceivably be used to select two candidate
peptides that are structurally appropriately separated in
the 3D model such that they would a priori generate Abs
able to react with the protein in a sandwich assay (i.e., an
assay in which the protein Ag, in solution, is captured by
two different Abs). As an example of such an application
of PEPOP, Figure 4A shows the localization of peptide #1
and peptide #4 on the 3D structure of IA-2. Peptide #1
corresponds to an α-helical part of the PTP domain of IA-
2, whereas peptide #4 maps to a hairpin in the juxta-mem-
brane domain. These peptides clearly belong to spatially
opposite regions on the protein. The resulting anti-pep-
tide Abs were used in a sandwich ELISA to validate their
capacity to simultaneously bind the cognate Ag. The
results (Figure 4B) demonstrate the possibility to use
PEPOP to target specific regions of the protein so as to
obtain a pair of Abs able to capture and quantify the pro-
tein of interest in solution.
Discussion
This work was conducted in the context of an abundance
of epitope predictive methods based on protein sequence
information and a relative scarcity of methods using 3D
information. Since the majority of Abs against protein Ags
binds to discontinuous sites, predictive methods should
take into account structural information and try to guess
the identity of discontinuous epitopes. This idea has
recently been taken into account by a few groups of inves-
tigators [21-24].
PEPOP is a two-purpose algorithm. On the one hand, it
allows the identification of clusters of accessible surface
residues and segments that might correspond to antigenic
epitopes, and on the other hand, it is able to design pep-
tides that can be used to prepare Abs that target the cog-
nate Ag at specific sites on its molecular surface. From the
3D structure of a protein, PEPOP identifies segments com-
Table 3: Reactivity with the cognate Ag of the Abs obtained by immunization with the peptides
Method2 
Ag Peptide # Peptide sequence1 Reference 
segment3
Method of 
extension4
Area of extension5 A450 nm for serum diluted 
1:10 0006
IA-2 1 VSSQFSDAAQASPS B 1.75
2 SPSSHSSTPSWCEEP B 0.30
3 RYWPDEGASLYHVYEV B 0.36
4 ALTAVAEEVNAILKALPQ L FPS - 3.62
5 NAILKALPQVKEIDLTAE L NN CC 0.14
6 qplaklianeatledksr L NNd CC 0.02
7 diekvgkaGPGNAILKALPQ L MD CC 0.02
8 ARIKLKVESSPSRSDYIN T FPS SC 1.83
TPO 9 VVTDDDRYSDLLMAWGQ B 3.76
10 ARLRDSGRAYLPFVPP B 0.46
11 PYEGYDSTANPTVSNVF B 0.06
12 EDFESCDSIPGMNLEA B 0.39
13 RRLDASFQEHPDLPGLWLH L FPS - 3.75
14 ASFQEHPDLPGRLWQFVLS L NN CC 0.33
15 APEPGIPGERPCPPRAPAA T NN TC 0.47
16 ASFQEHPDLPGRAPEPGIPGE L MD CC 0.14
IL8 17 PKFIKELRVIESGPHCANT L FPS - 0.16
18 ENWVQRVVEKFLKRAENS T FPS SC 2.25
1 Amino acids in lower case are D-amino acids. 2 Algorithm used to predict the sequence of the immunogenic peptide: B for BEPITOPE otherwise 
PEPOP. 3 The reference segment chosen is the longest (L: longest) or the segment at the top (T) of the list of all the segments ranked according to 
the five characteristics indicated in the text. 4 The method of extension chosen is either elongation with the flanking protein sequence (FPS); 
addition of the nearest neighbor (NN) segment(s) regardless of the sense of the segment added: if the segment is in the unnatural sense, i.e., from 
the C-terminus to the N-terminus, it is synthesized using D-amino acids (NNd); or manual design (MD). 5 The area of extension is the cluster top of 
the list (TC: top cluster) of the clusters ranked according to the five characteristics (see the text), or the cluster containing the selected reference 
segment (CC: containing cluster), or a user selected cluster (SC: selected cluster), or none when the reference segment is the longest and the 
method is the FPS. 6 Positive reactivities in the indirect ELISA are values over 0.2, and strong reactivities are values over 1.0. Control experiments 
done by using the preimmune serum gave values ranging from 0.0020 to 0.0028. The given values correspond to specific absorbances (A450 nm 
immune serum – A450 nm preimmune serum).BMC Bioinformatics 2008, 9:71 http://www.biomedcentral.com/1471-2105/9/71
Page 9 of 15
(page number not for citation purposes)
posed of one to n continuous surface accessible residues.
These segments are clustered according to their spatial
vicinity: thus, the clusters are proposed to be putative dis-
continuous epitopes. Segments and clusters are further
used to design putatively immunogenic peptides. Anti-
genicity is the ability of a protein to bind specifically to the
paratope of an Ab. Immunogenicity is the ability of an Ag
to induce an immune response in a suitable host. Thus,
antigenicity is just a molecular recognition phenomenon,
whereas immunogenicity depends on multiple factors
extrinsic to the sole Ag [30]. In developing and using
PEPOP, we have clearly distinguished these two proper-
ties and we show that the outputs of PEPOP could be used
in both settings. As concerns antigenicity, one has to keep
in mind that epitopes are in essence unpredictable since
epitopes are not intrinsic features of proteins but exist
only in the context of the Ab that binds to it [31]. Thus,
what one generally predicts is at best a putative epitope to
which an (undefined) Ab might bind. Our method, as all
others in the same vein, is a tool that helps experimental-
ists to focus on a defined part of a protein for experimen-
tally assessing its real antigenic character by measuring
antibody binding to this particular part.
A key step in proposing a new predictive tool is the dem-
onstration of its efficacy [32]. To evaluate the performance
of an algorithm to predict antigenicity seems rather easy
since it consists of comparing the predictions with known
epitopes. The gold standard for comparison is an epitope,
as defined by X-ray crystallography of an Ab-Ag complex
Sandwich immunoassay design for IA-2 Figure 4
Sandwich immunoassay design for IA-2. (A) 3D view. Peptide #1 (in red) and peptide #4 (in blue) are represented on 
the 3D structure of IA-2. (B) Graphic representation. The graph indicates the reactivity of the polyclonal (Abs) with IA-2, in a 
sandwich-type ELISA format. The Ag, captured by the immobilized Ab, is detected by a biotinylated Ab, followed by addition of 
streptavidin-peroxidase. Reactivity of×, anti-peptide #4 with IA-2, detected by anti-peptide #1;  , anti-peptide #4 with TPO, 
detected by anti-peptide #1;  , anti-peptide #15 with IA-2, detected by anti-peptide #1; , anti-peptide #15 with TPO, 
detected by anti-peptide #1.
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since this method provides a comprehensive topological
view of the epitope. However, it certainly counts as
epitope residues, some residues which are not energeti-
cally involved in the interaction with antigen (Novotny,
1989), and this may bias the comparison between pre-
dicted and epitopes defined by X-ray crystallography. The
authors of the three reported predictive algorithms that
make use of 3D information used different methods for
evaluation of the algorithm performances. Batori et al.
[22] reported results on a single Ab-Ag model, but they
rigorously compared the performances of their software
with that of sequence-based algorithms. As expected, their
EMT algorithm performed better than conventional meth-
ods [22,33]. To assess the performance of their DiscoTope
tool, Haste Andersen et al. [23] compared its predictions
with those obtained by the method of Parker et al. [14]
and by a surface accessibility calculation. They also
reported epitope prediction for a single antigen. The eval-
uation strategy developed by Kulkarni-Kale et al. [24] was
similar to the one we undertook. Their rationale for pre-
diction was also very similar to ours. It seems, however,
that their CEP algorithm tends to predict much larger anti-
genic determinants than PEPOP. Authors of the fourth
tool, the MEPS server [21], did not present any validation
data. The ability of PEPOP to identify putative antigenic
regions on proteins was evaluated by comparing 13 struc-
turally defined epitopes on a total of 8 different protein
Ags with the clusters calculated by the algorithm. The
identified clusters were shown to correspond to a large
(but not complete) extent to structurally defined epitopes.
In 11 out of the 13 Ab-Ag complexes analyzed, at least
50% of the structural epitope residues were found to be
included in a single PEPOP cluster. In the last two Ab-Ag
complexes [PDB: 1VFB, 1EY0], the predicted residues
almost equally distribute into three clusters, thus yielding
the lowest sensitivity numbers. It should be noted that our
method being based on detection of exposed residues, res-
idues buried in the structure that may participate to
epitopes are missed. CEP, EMT and DiscoTope also make
use of the accessibility parameter in their calculations. The
comparative assessment of sensitivity, specificity and pos-
itive predictive value of PEPOP, CEP, and DiscoTope
showed that PEPOP achieves similar or slightly better per-
formances than the other two algorithms.
As regards to immunogenicity, assessing the performance
of a tool to predict immunogenic peptides is more diffi-
cult because it implies time consuming experiments, nota-
bly immunizing animals. As others [34,35], we have made
this effort. To demonstrate the ability of PEPOP to suc-
cessfully predict immunogenic peptides, several peptides
were designed from the 3D structure of three model Ags
using different methods; they were then chemically syn-
thesized and used to elicit Abs in rabbits. Since all pep-
tides induced a strong anti-peptide antibody response
(data not shown) and not all antibodies recognized the
cognate protein, it was assumed that antibodies did not
cross-react with a denatured antigen. The capacity of the
Abs to cross-react with the target Ag was taken as proof of
a successful prediction. The FPS method of peptide design
was found to be efficient to yield peptides able to induce
a strong Ab response against the cognate protein Ag since
an 80% success rate was achieved. The FPS method pro-
vides a peptide with a sequence made from contiguous
residues of the protein, thus the 3D information is lost.
However, as compared with peptides designed by using
BEPITOPE [18], the FPS method of PEPOP performed bet-
ter. Both PEPOP and BEPITOPE use the β-turn criteria to
predict epitope (assignment in PEPOP, propensity of the
antigen sequence in BEPITOPE). PEPOP, however, uses
four additional parameters, the length of the segment, its
hydrophobicity, its accessibility as well as the occurrence
of R, W, Y, and P, that have been found to be overrepre-
sented in protein-protein interfaces [36]. It is possible that
this aggregated information might add some value to the
prediction simply based on β-turn propensity. Note, how-
ever, that the performances of BEPITOPE have recently
been surpassed by machine learning approaches [37]. A
disappointing observation was that our attempts to design
peptides mimicking discontinuous regions of the Ags
were not fully successful, in that the corresponding Abs
were poorly or not at all cross-reactive with the cognate
protein. Cross-reactive antibodies were obtained with sev-
eral peptides (designed notably using the NN method),
but their reactivity was low as compared with FPS-based
antibodies. Chemically mimicking discontinuous protein
surfaces have been a long-standing scientific challenge
[38]. We are nevertheless confident that this could be
amenable since many mimotopes have been identified
that are considered as low molecular weight functional
replicas of discontinuous epitopes [39]. As the PEPOP
software has only recently been developed, many param-
eters can probably be improved to better predict discon-
tinuous peptides. For example, the scoring and ranking of
the segments can be adjusted and the combination of one
to five of the characteristics deserves to be thoroughly
tested. Although PEPOP has proved its capacity to predict
relevant clusters and immunogenic peptides, it still con-
tains a great potential for improvement, particularly if a
prediction  → experimental validation → optimization
loop is implemented. PEPOP is flexible and can be a use-
ful tool for different purposes. For example, in an anti-
genic use, PEPOP can help to map an epitope by building
up a small virtual peptide library that can then be tested
for binding to the Ab; should the Ab recognize a peptide,
the epitope is localized. PEPOP has also the potential to
predict mimotopes, i.e. peptides without sequence simi-
larity with the Ag sequence which are recognized by the
mAb. Mimotopes can have many applications and lead to
pharmacological target identification (interesting for drugBMC Bioinformatics 2008, 9:71 http://www.biomedcentral.com/1471-2105/9/71
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design or guided docking), to protein engineering, vaccine
design, identification of protein function, etc. As concerns
immunogenicity, PEPOP can be used to target a specific
region of a protein or to obtain Abs that capture the Ag.
The need for mAbs to characterize proteins identified by
large-scale proteomic studies is ever increasing. Since the
protein itself is not always available, the interest in devel-
oping a method using peptides as surrogate Ags may have
great potential. An interesting feature of the PEPOP algo-
rithm is its possibility to propose putative immunogenic
peptides that could yield Abs suitable for a sandwich cap-
ture assay of any protein Ag that can be modeled. With the
advent of large-scale proteomic studies and Ab arrays,
there is an increasing need for such immunoassays
[40,41]. An ideal pipeline to fit these requirements would
rely on novel high-throughput modeling capacities [42]
and bioinformatics tools like PEPOP to select peptides so
as to obtain in a straightforward way pairs of surface-tar-
geted Abs for developing sandwich assays for diagnostic
or discovery purposes.
Conclusion
PEPOP can identify epitopes at the surface of proteins
with accuracy comparable to similar tools available
through web interface. Moreover, PEPOP can also be used
to design immunogenic peptides from the 3D coordinates
of the protein.
Methods
PEPOP algorithm
Clustering of the accessible surface segments
From the 3D structure of a protein, the solvent accessible
surface area is calculated (Figure 1A, step 1). The surface
accessibility of amino acids is determined by using DSSP
[43] with the default parameters. Segments composed of
accessible and contiguous amino acids are then listed (a
segment can be constituted by a single amino acid) (Fig-
ure 1A, step 2). Each segment is then approximated to a
geometric segment represented by three points: the first
two points are the Cα of the N-terminal and C-terminal
residues of the segment, the third point is calculated as the
mid-point between the other two. Hence, a segment is
represented by the 3D coordinates (X, Y, Z) of the three
characteristic points. A distance matrix is then calculated
in which the comparison between two segments produces
nine values since a segment is represented by three points.
A matrix of the shortest distances is then derived in which
the distance between two segments is represented by the
lowest value among the nine previously calculated. This
matrix is used to cluster the segments (Figure 1A, step 3).
The clustering of the segments is performed by Kitsch
(from PHYLIP package v3.6) [44]. At this stage, a set of
accessible surface segments is identified and segments
clustered based on the shortest distance matrix.
Scoring the segments
A score is attributed to the segments of a given list (either
the segments of a cluster or all the segments identified) for
each selected property (segment length, segment accessi-
bility, segment hydrophobicity, occurrence of particular
amino acids, and occurrence of residues in β-turns). The
length score is the number of amino acids in a segment.
The accessibility score is the average accessibility of the
amino acids composing the segment (values from DSSP).
The hydrophobicity score is the number of hydrophobic
amino acids (Y, W, F, L, V, I, C, P, M) in the segment. The
particular amino acid score is the number of W, R, Y and
P in the segment. The β-turn score is the number of amino
acids involved in a β-turn (DSSP assignment).
Scoring the clusters
Each cluster is scored for the five properties according to
the score of the composing segments. The length score of
a cluster is the length of the longest segment of this cluster.
The accessibility score is the number of segments of the
cluster being part of the first quartile of the most accessi-
ble segments. The hydrophobicity score is the sum of the
hydrophobic amino acids of the segments contained in
the cluster. The particular amino acid score is the sum of
W, R, Y, and P of the segments contained in the cluster.
The β-turn score is the sum of amino acids implied in a β-
turn of the segments contained in the cluster.
Ranking the segments or the clusters
The segments or the clusters are ranked for each of the five
properties according to the assigned score. The five ranks
of a segment or a cluster are summed, and the segments or
clusters are finally ranked according to these sums.
Methods to design immunogenic peptides
To design a peptide, a "reference segment" is chosen from
the set of identified segments and its sequence extended
with residues selected by a "method of extension" in a
specified "area of extension". The reference segment can
be manually selected among all the segments if a particu-
lar region of the protein is desired to be targeted and so
present in the final peptide. Otherwise, the PEPOP algo-
rithm is devised to automatically select the first ranked
segment according to criteria selected among the five
physicochemical or structural properties of the amino
acids. These parameters were chosen in agreement with
different analyses of Ab-Ag and/or protein-protein inter-
actions (among them [45,46]) that have shown that they
play a role in or they favorably influence the antigenicity
and even the immunogenicity of a protein, or they are
favorably associated with the binding between proteins.
In the PEPOP software, these five characteristics can be
chosen one by one or combined. The segments are ranked
according to the chosen characteristics within each seg-
ment: the top scored segment is automatically selected asBMC Bioinformatics 2008, 9:71 http://www.biomedcentral.com/1471-2105/9/71
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the reference segment. In a second step, the reference seg-
ment is elongated to yield a peptide of a suitable molecu-
lar size. Three methods of extension have been
implemented. The simplest is the extension of both sides
of the sequence of the reference segment with the flanking
sequence of the cognate protein (called FPS for Flanking
Protein Sequence). In the second method (called NN for
nearest neighbours), the segments having the shortest dis-
tance from the reference segment are searched for by the
algorithm. The sequence of the segment nearest to the C-
terminus of the reference segment is added C-terminally
(Figure 3). If necessary, a further extension is conducted in
the same way, from the last segment added until a defined
total minimal length of the peptide sequence is reached.
The third method is the search for an optimized path
between the segments composing a peptide (called ONN
for optimized nearest neighbor path). From a set of seg-
ments that composes a peptide, all the possible combina-
tions are explored to select the one for which the global
distance between all the segments is the shortest. The last
element for the design of the peptide is the choice of the
area of extension. The elongation of the peptide can take
into account either the whole set of accessible segments
from the protein or only a previously determined cluster
of accessible segments. This cluster can be chosen among
all clusters by the user, or it is automatically selected by
the algorithm in the same way as the reference segment
was automatically selected. Thus, the clusters are ranked
according to the same previously described five character-
istics that can be combined: accessibility, length, hydro-
phobicity, number of R, W, Y, P, and number of β-turns.
The cluster having the best rank according to the selected
parameters is selected as the area of extension.
Implementation details
PEPOP has been implemented on a Linux server (Dell
PE2250 virtualized server with the Mandriva 2007 OS dis-
tribution) running the Apache web server version 2.0. The
algorithm has been implemented in object oriented PHP
(version 5), which allows the simultaneous development
of the web interface. The segments and clusters identified
by PEPOP can be directly visualized on the 3D structure of
the Ag thanks to the plug-in Chime [47]. Further develop-
ment will allow the prediction and display of several pep-
tides at the same time.
Comparison of the PEPOP performances with that of 
other available epitope prediction tools
The performances of PEPOP were compared with the two
other available epitope tools, i. e. DiscoTope and CEP by
calculating specificity, sensibility, and positive predictive
value derived from a two-by-two contingency table
[48,49]:
where Sp is the specificity, Se the sensibility, PPV the Pos-
itive Predictive Value, and TN the number of amino acids
not predicted and actually not part of the epitope, TP the
number of predicted amino acids that are actually part of
the epitope, FP the number of predicted amino acids not
part of the epitope, and FN the number of amino acids not
predicted but part of the epitope. Therefore, the specificity
evaluates the capacity of the tool to exclude those amino
acids that are not part of the epitope, and the sensibility
measures the capacity of the tool to identify the amino
acids of the epitope. The positive predictive value is the
proportion of predicted amino acids that are truly part of
the epitope.
Note that the outputs of the three epitope prediction tools
are different. DiscoTope yields a single prediction, identi-
fying along the protein sequence the amino acids that
might belong to an epitope. Instead, PEPOP and CEP sug-
gest several potential epitopes. By grouping the segments,
PEPOP identifies a few exclusive clusters, i.e., the poten-
tial epitopes are not overlapping. CEP proposed several
CE (conformational epitope) that may or may not be par-
tially overlapping. For each of the 13 epitope predictions,
the Sp, Se, and PPV were calculated on the single proposi-
tion of DiscoTope, and on the cluster (for PEPOP) and the
CE (for CEP) giving the best values.
3D structures of IA-2, TPO, and IL8
The intracytoplasmic part of insulinoma associated anti-
gen 2 (IA-2) ([Swiss-Prot: Q16849] residues 601–979) is
composed of two domains: the juxta-membrane domain
(residues 601–690) and the PTP domain (residues
691–979). A theoretical model of the PTP domain of IA-2
was previously published by Dromey et al. [50] but was
not made available in the PDB [51]. Consequently, a new
theoretical model was calculated (Moreau, Valera et al., in
preparation) to determine the 3D coordinates of the struc-
ture. The human thyroïd peroxidase (TPO) [Swiss-Prot:
P07202] contains a large extracytoplasmic domain (resi-
dues 15–846) composed of four domains: a structurally
undefined domain (residues 15–140), a MPO-like
domain (141–740), a CCP-like domain (residues
741–795), and an EGF-like domain (residues 796–839).
A theoretical model of the MPO-like domain has been
reported [52] and was made available to us. The inter-
leukin-8 (IL8) [Swiss-Prot: P10145] is composed of a sin-
gle domain of about 70 amino acids, depending on the
variant. Its 3D structure is available in PDB [PDB: 3IL8].
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Peptide predictions
The PEPOP predictions were made with the 3D structures
of the PTP domain of IA-2, the MPO-like domain of TPO
and the entire IL8. BEPITOPE was used with the default
parameters on the Pellequer's TURN33 addition method.
The predicted epitopes proposed were ranked according
to the average value. The overlapping regions are consid-
ered as a unique predicted epitope. The sequences used
were the intracytoplasmic part of IA-2, the extracytoplas-
mic part of TPO, and the entire sequence of IL8.
Peptide synthesis and purification
Peptides were prepared by Fmoc solid-phase synthesis
using an AMS 422 robot or a MultiPep synthesizer
(INTAVIS AG, Germany). Peptides were tagged by adding
the tripeptide Cys-Tyr-Gly N- or C- terminally to the target
sequence to facilitate monitoring at 280 nm during puri-
fication and to provide a thiol handle for coupling to a
protein carrier. The standard synthesis protocol [53] was
used throughout. Mass spectrometry (MALDI-Tof Voyager
DE, Applied Biosystems) was used to confirm the identity
of the synthetic peptide with the target sequence. Peptides
were coupled to keyhole limpet hemocyanin (KLH) by
using the heterobifunctional coupling reagent sulfo-
SMCC, according to the manufacturer's instructions.
Immunizations
New Zealand white rabbits (Centre Lago, France) were
immunized three times via the intradermic route at 14-
day intervals using 50 μg of Ag (KLH-coupled peptides)
and Freund's complete or incomplete adjuvant. Rabbits
were bled 10 days after the third immunization and the
serum titer measured by ELISA. The rabbits were boosted
twice subcutaneously at 21-day intervals with 50 μg of Ag
prior to terminal blood collection (by cardiac puncture).
Ab reactivity with the cognate protein
The entire IL8 (recombinant protein produced in E. coli)
was purchased from Peprotech.
Extracytoplasmic TPO was purchased from HyTest Ltd.
The intracytoplasmic part of IA-2 (residues 601–979) was
produced in the baculovirus-insect cell system in our lab-
oratory.
For indirect ELISA, maxisorp 96-well plates were coated
with 2 μg/ml of Ag in phosphate-buffered saline (PBS)
(overnight at 4°C). The plates were washed in PBS con-
taining 0.1% Tween-20 (PBS-T) and blocked with 2%
nonfat milk in PBS-T (1 h at 37°C). One hundred micro-
litres of serial dilutions of the final bleeds (1:5 000 to 1:1
000 000) in 2% nonfat milk PBS-T was added to each well
(2 h at 37°C). After three washes in PBS-T, the plates were
incubated with a peroxidase-conjugated anti-rabbit Ab
(Sigma), diluted 1:3 000 in PBS-T 2% nonfat milk (1 h at
37°C). Plates were washed four times in PBS-T and incu-
bated with OPD. After 20 min at room temperature, the
absorbance at 450 nm was measured.
For sandwich ELISA, maxisorp 96-well plates were coated
with 2 μg/ml of Protein A purified Ab (overnight at 4°C).
After blocking with 3% bovine serum albumin (BSA) in
PBS-T (1 h at 37°C), 100 μl of serial dilutions of the Ag
(0.01 μg/ml to 5 μg/ml in 3% BSA-PBS-T) was added (2 h
at 37°C) to each well. After three washes in PBS-T, the
plates were incubated with 2 μg/ml of a biotinylated-con-
jugated purified polyclonal Ab in 3% BSA-PBS-T (2 h at
37°C). After three washes in PBS-T, the plates were incu-
bated with peroxidase-conjugated streptavidin (Amer-
sham), diluted 1:3 000 in 3% BSA-PBS-T (1 h at 37°C).
Plates were washed four times in PBS-T and incubated
with OPD substrate for 20 min at room temperature. The
reaction was stopped by adding 50 μl of 4 N H2SO4 and
the absorbance at 490 nm was measured. In control exper-
iments, rabbit preimmune sera were tested in the above
conditions. The absorbance value noticed for each dilu-
tion was subtracted from the absorbance value given by
the corresponding dilution of the rabbit immune serum.
Availability and requirements
PEPOP is a server web based application and is usable as
a Sysdiag Service at http://diagtools.sysdiag.cnrs.fr/
PEPOP/. This service is plateform independent, fully
tested with Windows 2000™, Windows XP™. Program-
ming language: PHP; required the installation of the plug-
in Chime (not compatible with all the navigators) to vis-
ualize the results in the 3D structure of the protein.
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